A Study of LY3314814 in Healthy Participants

An Absolute Bioavailability Study of LY3314814 in Healthy Subjects Using an Intravenous Tracer Method

The purpose of this study is to measure how much LY3314814 gets into the bloodstream when it is given as a single dose by mouth and as an intravenous (IV) infusion over two hours. The study will last at least two weeks for each participant, not including screening.

Inclusion Criteria:

• Are overtly healthy males or females
• Have venous access sufficient to allow for blood sampling and intravenous (IV) administration of the investigational product

Exclusion Criteria:

• Have a history of significant ophthalmic disease
• Have vitiligo or any other clinically significant disorder of skin pigmentation
• Have a history of use of antipsychotic drugs, or chronic use of antidepressant or anxiolytic drugs, prescribed as well as non-prescribed